These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35571490)

  • 1. Methyltransferase-like 3 Aggravates HCC Development via Mediating N6-Methyladenosine of Ubiquitin-Specific Protease 7.
    Yuan D; Chen J; Hao Q; Zhang P; Chen Z
    J Oncol; 2022; 2022():6167832. PubMed ID: 35571490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL3 facilitates the progression of hepatocellular carcinoma by modulating the m6A level of USP7.
    Li Y; Cheng X; Chen Y; Zhou T; Li D; Zheng WV
    Am J Transl Res; 2021; 13(12):13423-13437. PubMed ID: 35035685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
    Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. m6A Methyltransferase 3 Promotes the Proliferation and Migration of Gastric Cancer Cells through the m6A Modification of YAP1.
    Zhou W; Xian Q; Wang Q; Wu C; Yan H; Li X; Lu L; Wu C; Zhu D; Xu X; Wu J
    J Oncol; 2021; 2021():8875424. PubMed ID: 34394353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.
    Miao W; Chen J; Jia L; Ma J; Song D
    Biochem Biophys Res Commun; 2019 Aug; 516(3):719-725. PubMed ID: 31253399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α.
    Yang N; Wang T; Li Q; Han F; Wang Z; Zhu R; Zhou J
    J Cell Physiol; 2021 May; 236(5):3863-3880. PubMed ID: 33305825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
    Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
    J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit-induced long intergenic non-protein coding RNA 1833 N6-methyladenosine methylation promotes the non-small cell lung cancer progression via regulating heterogeneous nuclear ribonucleoprotein A2/B1 expression.
    Li D; Fu Z; Dong C; Song Y
    Bioengineered; 2022 Apr; 13(4):10493-10503. PubMed ID: 35441574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The m6A methyltransferase METTL3 promotes the stemness and malignant progression of breast cancer by mediating m6A modification on SOX2.
    Xie J; Ba J; Zhang M; Wan Y; Jin Z; Yao Y
    J BUON; 2021; 26(2):444-449. PubMed ID: 34076991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.
    Xie W; Ma LL; Xu YQ; Wang BH; Li SM
    Biochem Biophys Res Commun; 2019 Oct; 518(1):120-126. PubMed ID: 31405565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. m6A methyltransferase METTL3 promotes the progression of prostate cancer via m6A-modified LEF1.
    Ma XX; Cao ZG; Zhao SL
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3565-3571. PubMed ID: 32329830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10.
    Cai J; Cui Z; Zhou J; Zhang B; Lu R; Ding Y; Hu H
    Cancer Cell Int; 2022 Dec; 22(1):385. PubMed ID: 36476503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUMO1 modification of methyltransferase-like 3 promotes tumor progression via regulating Snail mRNA homeostasis in hepatocellular carcinoma.
    Xu H; Wang H; Zhao W; Fu S; Li Y; Ni W; Xin Y; Li W; Yang C; Bai Y; Zhan M; Lu L
    Theranostics; 2020; 10(13):5671-5686. PubMed ID: 32483411
    [No Abstract]   [Full Text] [Related]  

  • 15. METTL3 suppresses neuropathic pain via modulating N6-methyladenosine-dependent primary miR-150 processing.
    Zhang L; Zhao X; Wang J; Jin Y; Gong M; Ye Y; Li P
    Cell Death Discov; 2022 Feb; 8(1):80. PubMed ID: 35210391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. F-Box Protein 43, Stabilized by N6-Methyladenosine Methylation, Enhances Hepatocellular Carcinoma Cell Growth and Invasion via Promoting p53 Degradation in a Ubiquitin Conjugating Enzyme E2 C-Dependent Manner.
    Zhou H; Zeng C; Liu J; Luo H; Huang W
    Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
    Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
    Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis.
    Zhao C; Ling X; Xia Y; Yan B; Guan Q
    Cancer Cell Int; 2021 Aug; 21(1):441. PubMed ID: 34419065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF.
    Cheng Y; Fu Y; Wang Y; Wang J
    Front Genet; 2020; 11():955. PubMed ID: 33061938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methyltransferase-Like 3-Mediated m6A Methylation of Hsa_circ_0058493 Accelerates Hepatocellular Carcinoma Progression by Binding to YTH Domain-Containing Protein 1.
    Wu A; Hu Y; Xu Y; Xu J; Wang X; Cai A; Liu R; Chen L; Wang F
    Front Cell Dev Biol; 2021; 9():762588. PubMed ID: 34888309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.